All Stories

  1. TBK1 activity regulates the directionality of axonal transport of signalling endosomes
  2. CNTF specifically slows down the axonal transport of signalling endosomes
  3. TBK1 activity regulates the directionality of axonal transport of signalling endosomes
  4. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in mice with advanced age
  5. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in aged mice
  6. Shared mechanisms and pathological phenotypes underlying aminoacyl-tRNA synthetase-related neuropathies
  7. Refining gene delivery to skeletal muscle with a dual-strategy approach of muscle-tropic AAV capsids and muscle-specific promoters
  8. The tyrosine phosphatases LAR and PTPRδ act as receptors of the nidogen-tetanus toxin complex
  9. Age‐specific and compartment‐dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons
  10. The node of Ranvier influences thein vivoaxonal transport of mitochondria and signalling endosomes
  11. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy
  12. Targeting muscle to treat Charcot-Marie-Tooth disease
  13. Brain-derived neurotrophic factor amplifies neuron-intrinsic programs to enhance axonal regeneration in human motor neurons
  14. Age-specific and compartment-dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons
  15. Spinal Muscular Atrophy: A Rare but Treatable Disease of the Nervous System
  16. Boosting peripheral BDNF rescues impaired in vivo axonal transport in CMT2D mice
  17. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy
  18. In vivo imaging of axonal transport in peripheral nerves of rodent forelimbs
  19. Neuroscience highlights in 2022: cytoskeletal transport
  20. Intraperitoneal Injection of Neonatal Mice
  21. Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor
  22. Editorial: Peripheral nerve anatomy in health and disease
  23. BDNF-dependent modulation of axonal transport is selectively impaired in ALS
  24. Editorial: Pathways and Processes Underpinning Axonal Biology and Pathobiology
  25. Coupling axonal mRNA transport and local translation to organelle maintenance and function
  26. Expanding the Toolkit for <em>In Vivo</em> Imaging of Axonal Transport
  27. A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease
  28. BDNF-dependent modulation of axonal transport is selectively impaired in ALS
  29. Dissection, in vivo imaging and analysis of the mouse epitrochleoanconeus muscle
  30. NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
  31. NMJ-Analyser: high-throughput morphological screening of neuromuscular junctions identifies subtle changes in mouse neuromuscular disease models
  32. Altered Sensory Neuron Development in CMT2D Mice Is Site-Specific and Linked to Increased GlyRS Levels
  33. Intramuscular Delivery of Gene Therapy for Targeting the Nervous System
  34. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice
  35. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  36. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  37. Morphological variability is greater at developing than mature mouse neuromuscular junctions
  38. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice
  39. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  40. Altered sensory neuron development in CMT2D mice is site-specific and linked to increased GlyRS levels
  41. Post-synaptic morphology of mouse neuromuscular junctions is linked to muscle fibre type
  42. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
  43. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes
  44. Axonal Transport: The Delivery System Keeping Nerve Cells Alive
  45. In Vivo Imaging of Anterograde and Retrograde Axonal Transport in Rodent Peripheral Nerves
  46. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
  47. The evolution of the axonal transport toolkit
  48. Axonal transport and neurological disease
  49. Neuronal over-expression of OXR1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo
  50. Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition
  51. ALS mice carrying pathological mutant TDP-43, but not mutant FUS, display axonal transport defects in vivo
  52. UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy
  53. Plexin-Semaphorin Signaling Modifies Neuromuscular Defects in a Drosophila Model of Peripheral Neuropathy
  54. Antisense oligonucleotides and other genetic therapies made simple
  55. Aligned electrospun fibers for neural patterning
  56. Engineered method for directional growth of muscle sheets on electrospun fibers
  57. Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
  58. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis
  59. Sensory neuron fate is altered in human neuropathy caused by Gars mutations
  60. Methodological advances in imaging intravital axonal transport
  61. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular development and homeostasis
  62. Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
  63. Sensory neuron fate is developmentally perturbed by Gars mutations causing human neuropathy
  64. Axonal transport is unnaffected by aging
  65. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d
  66. A simple, step-by-step dissection protocol for the rapid isolation of mouse dorsal root ganglia
  67. Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy
  68. In vivo imaging of axonal transport in murine motor and sensory neurons
  69. The muscle is a major player in neuropathology of a fly model of peripheral neuropathy
  70. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles
  71. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
  72. Delayed motor neuron-muscle synapse development anticipates degeneration in peripheral neuropathy
  73. Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
  74. Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease
  75. Spinal muscular atrophy at the crossroads of basic science and therapy
  76. Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
  77. The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
  78. Conserved Genes Act as Modifiers of Invertebrate SMN Loss of Function Defects
  79. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds
  80. Functional analysis of nematode nicotinic receptors
  81. C. elegans models of neuromuscular diseases expedite translational research